$6.85
-0.14-2.00%
At close: -
$6.85
00.00%
After Hours: 4:36 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for AngioDynamics (ANGO) was reported on October 3, 2024 for the full year 2025. The company provided earnings per share guidance in the range of $-0.42 to $-0.38, compared to the estimated EPS of $-0.41. Additionally, AngioDynamics forecasted revenue between $0.28B and $0.29B for the quarter.
Browse guidance and forecast on all stocks.